UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tight junction proteins in gastrointestinal and liver disease

Gut, 2019-03, Vol.68 (3), p.547-561

2019

Volltextzugriff (PDF)

miR-122 – A key factor and therapeutic target in liver disease

Journal of hepatology, 2015-02, Vol.62 (2), p.448-457

2015

Volltextzugriff (PDF)

Host-targeting agents for prevention and treatment of chronic hepatitis C – Perspectives and challenges

Journal of hepatology, 2013-02, Vol.58 (2), p.375-384

2013

Volltextzugriff (PDF)

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents

PLoS pathogens, 2014-05, Vol.10 (5), p.e1004128-e1004128

2014

Volltextzugriff (PDF)

Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process

International journal of molecular sciences, 2020-03, Vol.21 (6), p.2091

2020

Volltextzugriff (PDF)

Hepatitis B Virus Evasion From Cyclic Guanosine Monophosphate–Adenosine Monophosphate Synthase Sensing in Human Hepatocytes

Hepatology (Baltimore, Md.), 2018-11, Vol.68 (5), p.1695-1709

2018

Volltextzugriff (PDF)

A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses

Hepatology (Baltimore, Md.), 2016-01, Vol.63 (1), p.35-48

2016

Volltextzugriff (PDF)

Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma

Viruses, 2018-10, Vol.10 (11), p.591

2018

Volltextzugriff (PDF)

Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry

Hepatology (Baltimore, Md.), 2014-03, Vol.59 (3), p.776-788

2014

Volltextzugriff (PDF)

Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma

Current opinion in virology, 2016-10, Vol.20, p.99-105

2016

Volltextzugriff (PDF)

Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors

PLoS pathogens, 2010-07, Vol.6 (7), p.e1000978-e1000978

2010

Volltextzugriff (PDF)

Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes

Journal of Virology, 2010-06, Vol.84 (11), p.5751-5763

2010

Volltextzugriff (PDF)

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

Proceedings of the National Academy of Sciences - PNAS, 2007-04, Vol.104 (14), p.6025-6030

2007

Volltextzugriff (PDF)

miR-122 acts as a tumor suppressor in hepatocarcinogenesis in vivo

Journal of hepatology, 2013-04, Vol.58 (4), p.821-823

2013

Volltextzugriff (PDF)

Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape

Gut, 2018-04, Vol.67 (4), p.736-745

2018

Volltextzugriff (PDF)

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection

Viruses, 2015-11, Vol.7 (11), p.5659-5685

2015

Volltextzugriff (PDF)

Reconstitution of the Entire Hepatitis C Virus Life Cycle in Nonhepatic Cells

Journal of Virology, 2012-11, Vol.86 (21), p.11919-11925

2012

Volltextzugriff (PDF)

Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design

Frontiers in immunology, 2018-06, Vol.9, p.1436-1436

2018

Volltextzugriff (PDF)

Characterization of Hepatitis C Virus Particle Subpopulations Reveals Multiple Usage of the Scavenger Receptor BI for Entry Steps

The Journal of biological chemistry, 2012-09, Vol.287 (37), p.31242-31257

2012

Volltextzugriff (PDF)

Plasmodium P36 determines host cell receptor usage during sporozoite invasion

eLife, 2017-05, Vol.6

2017

Volltextzugriff (PDF)

Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes

Cell reports (Cambridge), 2016-10, Vol.17 (5), p.1357-1368

2016

Volltextzugriff (PDF)

Host-targeting therapies for hepatitis C virus infection: current developments and future applications

Therapeutic Advances in Gastroenterology, 2018-01, Vol.11, p.1756284818759483-1756284818759483

2018

Volltextzugriff (PDF)

Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection

Viruses, 2016-09, Vol.8 (9), p.261

2016

Volltextzugriff (PDF)

The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination

Hepatology (Baltimore, Md.), 2013-02, Vol.57 (2), p.492-504

2013

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(104)

Publikationsform

Artikel
(129)
Buchkapitel
(1)

Sprache

Englisch
(119)
Französisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tight junction proteins in gastrointestinal and liver disease

miR-122 – A key factor and therapeutic target in liver disease

Host-targeting agents for prevention and treatment of chronic hepatitis C – Perspectives and challenges

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents

Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process

Hepatitis B Virus Evasion From Cyclic Guanosine Monophosphate–Adenosine Monophosphate Synthase Sensing in Human Hepatocytes

A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses

Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma

Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry

miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis

Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma

Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors

Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

miR-122 acts as a tumor suppressor in hepatocarcinogenesis in vivo

Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection

Reconstitution of the Entire Hepatitis C Virus Life Cycle in Nonhepatic Cells

Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design

Characterization of Hepatitis C Virus Particle Subpopulations Reveals Multiple Usage of the Scavenger Receptor BI for Entry Steps

Plasmodium P36 determines host cell receptor usage during sporozoite invasion

Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes

Host-targeting therapies for hepatitis C virus infection: current developments and future applications

Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection

The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination

Suchergebnisse filtern